PHOENIX: A new player bridging nano-pharmaceutical innovation from design to clinic
A online satellite event of ECCPM
Friday, 13 September 2024, 10:00 am – 12:00 pm
PHOENIX supports its customers to overcome difficulties bridging the “innovation valley of death”, enabling transfer of nanopharmaceuticals from lab bench to clinical trials. As an Open Innovation Test Bed (OITB), PHOENIX provides a Single Entry Point (SEP) for a network of facilities, technologies, services and expertise for all the R&D/I and technology transfer aspects from characterization, testing, verification up to scale-up, GMP manufacturing and regulatory guidance in a timely and cost-friendly manner.
Learn about the services of the PHOENIX Open Innovation Test Bed in the following areas:
- Physico-Chemical Characterisation
- In vitro Characterisation
- In vivo Characterisation
- Manufacturing
- Innovation (including regulatory aspects)
Register below!